146 related articles for article (PubMed ID: 20858479)
1. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
[TBL] [Abstract][Full Text] [Related]
3. C-Phycocyanin inhibits 2-acetylaminofluorene-induced expression of MDR1 in mouse macrophage cells: ROS mediated pathway determined via combination of experimental and In silico analysis.
Roy KR; Arunasree KM; Dhoot A; Aparna R; Reddy GV; Vali S; Reddanna P
Arch Biochem Biophys; 2007 Mar; 459(2):169-77. PubMed ID: 17303067
[TBL] [Abstract][Full Text] [Related]
4. Alteration of mitochondrial membrane potential by Spirulina platensis C-phycocyanin induces apoptosis in the doxorubicinresistant human hepatocellular-carcinoma cell line HepG2.
Roy KR; Arunasree KM; Reddy NP; Dheeraj B; Reddy GV; Reddanna P
Biotechnol Appl Biochem; 2007 Jul; 47(Pt 3):159-67. PubMed ID: 17274761
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
[TBL] [Abstract][Full Text] [Related]
6. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells.
Komori Y; Arisawa S; Takai M; Yokoyama K; Honda M; Hayashi K; Ishigami M; Katano Y; Goto H; Ueyama J; Ishikawa T; Wakusawa S
Eur J Pharmacol; 2014 Feb; 724():161-7. PubMed ID: 24370495
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
10. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
Achari C; Reddy GV; Reddy TC; Reddanna P
Med Chem; 2011 Sep; 7(5):432-42. PubMed ID: 21801152
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappaB, and AP-1 in SK-N-SH cells: Role of PGE(2) in viral replication.
Tung WH; Hsieh HL; Yang CM
Cell Signal; 2010 Feb; 22(2):234-46. PubMed ID: 19800403
[TBL] [Abstract][Full Text] [Related]
12. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
13. Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells.
Pan YY; Xu SP; Jia XY; Xu HQ; Zhang Y; Rui LX; Wei W
Exp Oncol; 2007 Mar; 29(1):23-9. PubMed ID: 17431384
[TBL] [Abstract][Full Text] [Related]
14. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
Sun L; Chen W; Qu L; Wu J; Si J
Mol Med Rep; 2013 Dec; 8(6):1883-7. PubMed ID: 24145579
[TBL] [Abstract][Full Text] [Related]
15. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
Chiu WT; Shen SC; Chow JM; Lin CW; Shia LT; Chen YC
Neurobiol Dis; 2010 Jan; 37(1):118-29. PubMed ID: 19804834
[TBL] [Abstract][Full Text] [Related]
16. Modulation of IgE-dependent COX-2 gene expression by reactive oxygen species in human neutrophils.
Vega A; Chacón P; Alba G; El Bekay R; Martín-Nieto J; Sobrino F
J Leukoc Biol; 2006 Jul; 80(1):152-63. PubMed ID: 16624933
[TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
Tran TP; Kim HG; Choi JH; Na MK; Jeong HG
Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342
[TBL] [Abstract][Full Text] [Related]
18. Isoobtusilactone A-induced apoptosis in human hepatoma Hep G2 cells is mediated via increased NADPH oxidase-derived reactive oxygen species (ROS) production and the mitochondria-associated apoptotic mechanisms.
Chen CY; Liu TZ; Chen CH; Wu CC; Cheng JT; Yiin SJ; Shih MK; Wu MJ; Chern CL
Food Chem Toxicol; 2007 Jul; 45(7):1268-76. PubMed ID: 17321026
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
[TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
